37
Participants
Start Date
July 31, 2012
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
pegylated IFN
Patients are treated with 180µg of pegylated IFN (Pegasys-Roche) subcutaneously weekly for three months.
Biobran
Biobran, at a dose of 1g per day, allocated in packets, taken orally with meals for the three months duration of the study. Biobran is a denatured hemicellulose that is obtained by reacting rice bran hemicellulose with multiple carbohydrate hydrolyzing enzymes from Shiitake mushrooms. It is a polysaccharide that contains ß-1, 3-glucans, and activated hemicellulose. Biobran was kindly provided by Daiwa Pharmaceuticals Co. Ltd., Tokyo, Japan.
Ribavirin
Ribavirin is prescribed according to patients body weight (1200 mg for those over 75 kg and 1000 mg for those under 75 kg).
Daiwa Pharmaceutical Corporation Co, Ltd, Tokyo 154-0024 Japan
UNKNOWN
University of California, Los Angeles
OTHER
Cairo University
OTHER